1-15 of 15
Mehdi M. Moezi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma

Leena Chhun, Dmytro Assonov, Jennifer Wren, Cheng Zheng, Jayne Piboonvaranggoon, Brianna Stumph, Kati O'Brien, Caroline Merillat, Jessica Faucheaux, Sophia Essiet, Tara Graff, Patrick M. Travis, Sibel Blau, Caleb J Scheckel, Frank Mark Senecal, Ayed Ayed, Mehdi M. Moezi, Shannon Altimari, Brian Decker, Robert McCroskey, Jaime Miller, Mark Walker, C. Anthony Blau
Journal: Blood
Blood (2024) 144 (Supplement 1): 5043.
https://doi.org/10.1182/blood-2024-194268
Published: 2024
Journal Articles

A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone

James R Berenson, Andrea Limon, Stephanie Rice, Tahmineh Safaie, Ralph Boccia, Honghao Yang, Mehdi M. Moezi, Stephen Lim, Gary Schwartz, Shahrooz Eshaghian, Matthew Brobeck, Regina Swift, Benjamin M. Eades, Sean Bujarski, Yohana Sebhat, Rudra Ray, Susanna Kim, Robert Allen Vescio
Journal: Blood
Blood (2023) 142 (Supplement 1): 4753.
https://doi.org/10.1182/blood-2023-180287
Published: 2023
Journal Articles

Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma

Mehdi M. Moezi, Mohamad Kanaan, Patrick M. Travis, Tara Graff, Cheng Zheng, Jessa Dunivan, Tiffany Wood, Sophia Essiet, Jessica Faucheaux, Brian Decker, Jennifer Wren, Leena Chhun, Jayne Piboonvaranggoon, Mark Walker, Trudy Buckingham, Joseph Guidi, Shannon Altimari, C. Anthony Blau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3375.
https://doi.org/10.1182/blood-2023-187234
Published: 2023
Journal Articles

The Safety and Efficacy of Fostamatinib in Patients with Chronic Immune Thrombocytopenic Purpura Treated in a Real-World Community Hematology Setting

Mehdi M. Moezi, Aaron Peevyhouse, Tiffany Wood, Yuliya Kreychman, George Dranitsaris
Journal: Blood
Blood (2022) 140 (Supplement 1): 5135–5136.
https://doi.org/10.1182/blood-2022-170529
Published: 2022
Journal Articles

Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple Myeloma

James R. Berenson, Daisy Martinez, Tahmineh Safaie, Ralph Boccia, Honghao H Yang, Mehdi M. Moezi, Stephen Lim, Gary Edward Schwartz, Shahrooz Eshaghian, Regina Swift, Benjamin Eades, Sean Elliott Bujarski, Bernard Sean Regidor, Clara Kim, Susanna Kim, Robert Vescio
Journal: Blood
Blood (2022) 140 (Supplement 1): 12610–12611.
https://doi.org/10.1182/blood-2022-163872
Published: 2022
Journal Articles

Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma

James R. Berenson, Daisy Martinez, Tahmineh Safaie, Noemi Silagan, Jennifer To, Tanya M. Spektor, Eli Forouzan, Regina Swift, Benjamin Eades, Shahrooz Eshaghian, Gary Schwartz, Ralph V. Boccia, Honghao H Yang, Mehdi M. Moezi, Stephen Lim, Robert Vescio
Journal: Blood
Blood (2021) 138 (Supplement 1): 2727.
https://doi.org/10.1182/blood-2021-151016
Published: 2021
Journal Articles

Characteristics of a Comprehensive, Continuously Updated Longitudinal Database for Multiple Myeloma

C. Anthony Blau, Grace Nam, Leena Chhun, Cheng Zheng, Jayne Piboonvaranggoon, Jennifer Wren, Elora Mallick, Lauren Zelko, Michiko Wolcott, Carmen Lopez, Swathi Namburi, Sibel Blau, Francis M. Senecal, Robert McCroskey, Mehdi M. Moezi, Ayed O. Ayed, Ricardo Lopez Barquilla, Joshua Richter, William I. Bensinger, Paul G. Richardson, Kenneth C. Anderson
Journal: Blood
Blood (2021) 138 (Supplement 1): 4969.
https://doi.org/10.1182/blood-2021-148399
Published: 2021
Journal Articles

Incidence, Clinical Profile and Outcome of Patients with Deep Vein Thrombosis and Pulmonary Embolism at a Community Hospital

Pragathi Balakrishna, MD, Mehdi M. Moezi, MD, Furquan Pathan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5585.
https://doi.org/10.1182/blood.V130.Suppl_1.5585.5585
Published: 2017
Journal Articles

Efficacy and Safety of Ofatumumab and Bendamustine Followed By Ofatumumab Maintenance in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma after Prior Rituximab

Kathryn S. Kolibaba, MD, Mikhail Shtivelband, MD PhD, Edwin C. Kingsley, MD, Mehdi M. Moezi, MD, Donald Richards, MD PhD, Jeffrey P. Sharman, MD, Feng Xiaoshu, MS, Megan Cannan, B.S, Rafik Fellague-Chebra, MD, Roger M. Lyons, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1500.
https://doi.org/10.1182/blood.V130.Suppl_1.1500.1500
Published: 2017
Journal Articles

A Retrospective Study to Evaluate the Incidence and Severity of Peripheral Neuropathy for Relapsed/Refractory Multiple Myeloma Patients upon Retreatment with Bortezomib

James R. Berenson, MD, Jacob D. Bitran, MD, Imad Tabbara, MD FACP, Jose Lutzky, MD, Laura V. Stampleman, MD, Sikander Ailawadhi, MD, Ronald Steis, MD, Mehdi M. Moezi, MD
Journal: Blood
Blood (2014) 124 (21): 3469.
https://doi.org/10.1182/blood.V124.21.3469.3469
Published: 2014
Journal Articles

A New Multinational Observational Study In Multiple Myeloma: Initial Report Of The PREAMBLE Study

Ravi Vij, MD, Mehdi M. Moezi, MD, Robin Foà, MD, Gordon Cook, MD, PhD, Antonio Palumbo, MD, Hakan Kaya, MD, Brian Durie, MD, David Cella, PhD, Lieven Annemans, PhD, Yun Su, MD, Pralay Mukhopadhyay, PhD, Trong K. Le, MPH, MS, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2013) 122 (21): 1964.
https://doi.org/10.1182/blood.V122.21.1964.1964
Published: 2013
Journal Articles

Zoledronic Acid (ZOL) Markedly Improves Bone Mineral Density (BMD) for Patients (Pts) with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Bone Loss.

James R. Berenson, MD, Ori Yellin, MD, Ralph V. Boccia, MD, Marshall S. Flam, MD, Siu-Fun Wong, PharmD, Olcay Batuman, MD, Mehdi M. Moezi, MD, Donald Woytowitz, MD, Herb Duvivier, MD, Youram Nassir, MD, Regina A. Swift, RN
Journal: Blood
Blood (2007) 110 (11): 3606.
https://doi.org/10.1182/blood.V110.11.3606.3606
Published: 2007
Journal Articles

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage II, III or IV Chronic Lymphocytic Leukemia (CLL).

Raul R. Mena, MD, Mehdi M. Moezi, MD, Robert L. Robles, MD, Maureen Cooper, MD
Journal: Blood
Blood (2007) 110 (11): 1356.
https://doi.org/10.1182/blood.V110.11.1356.1356
Published: 2007
Journal Articles

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage II, III or IV CLL.

Raul R. Mena, MD, Robert Robles, MD, Michael Auerbach, MD, Mehdi M. Moezi, MD, David Headley, MD
Journal: Blood
Blood (2006) 108 (11): 4978.
https://doi.org/10.1182/blood.V108.11.4978.4978
Published: 2006
Journal Articles

First-Line Treatment of Multiple Myeloma with a Combination of Thalidomide, Dexamethasone, and Zoledronate (TDZ) in an Inner-City Population with High HIV Prevalence.

Uwe Klueppelberg, MD PhD, Eric Smith, PhD, Laurie Chen, MD, Chona M. Aloba, MD, Iuliana Shapira, MD, Mehdi M. Moezi, MD, Olcay Batuman, MD
Journal: Blood
Blood (2004) 104 (11): 4932.
https://doi.org/10.1182/blood.V104.11.4932.4932
Published: 2004